• FDA 510(k) Clearance of the Rover received in July 2020 - commercially available in the United States • $2.1M of Nano units built and shipped to customers during the Quarter • Significant increase in Nano production and inventory to meet further COVID-19 demand • Removed backlog of Nano orders – now able to meet < 4 week delivery times • Nano Orders of $0.2M for July to date • Submission for $14.6M of funding to develop Stroke Diagnostic Imaging technology • $15m Capital raise completed – including new institutional investors • Closing cash balance of $18.3M, expected to fund the company into 2022
Plenty of positive/upbeat forecasts with various projects in the pipeline/progressing during 2020/21
